In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
about
Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imagingHybrid nanoparticles for detection and treatment of cancerToxicity of nanomaterialsUltrasound exposure improves the targeted therapy effects of galactosylated docetaxel nanoparticles on hepatocellular carcinoma xenograftsDouble-scattering/reflection in a single nanoparticle for intensified ultrasound imaging.Luminescent GdVO4:Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery.Spatiotemporally and Sequentially-Controlled Drug Release from Polymer Gatekeeper-Hollow Silica Nanoparticles.Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacyStepwise encapsulation and controlled two-stage release system for cis-Diamminediiodoplatinum.Targeting gold nanoshells on silica nanorattles: a drug cocktail to fight breast tumors via a single irradiation with near-infrared laser light.Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-κB signaling pathway.Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.Multifunctional Nd(3+)-sensitized upconversion nanomaterials for synchronous tumor diagnosis and treatment.Formation of hollow silica nanospheres by reverse microemulsion.Ligand-targeted theranostic nanomedicines against cancerInfluence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance thresholdFunctionalization of Carbon Nanomaterial Surface by Doxorubicin and Antibodies to Tumor Markers.An efficient direct competitive nano-ELISA for residual BSA determination in vaccines.Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates.Facile synthesis of soybean phospholipid-encapsulated MoS2 nanosheets for efficient in vitro and in vivo photothermal regression of breast tumor.Size-dependent tumor penetration and in vivo efficacy of monodisperse drug-silica nanoconjugates.How nanotechnology can enhance docetaxel therapy.Nonporous Silica Nanoparticles for Nanomedicine Application.Silica Nanoparticles Target a Wnt Signal Transducer for Degradation and Impair Embryonic Development in Zebrafish.Preparation of magnetic mesoporous silica nanoparticles as a multifunctional platform for potential drug delivery and hyperthermia.Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.Spherical silica micro/nanomaterials with hierarchical structures: synthesis and applications.Functionalized nanostructures with application in regenerative medicine.Docetaxel nanotechnology in anticancer therapy.Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer.Current development in nanoformulations of docetaxel.Self-templating synthesis of hollow mesoporous silica and their applications in catalysis and drug delivery.The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery.Nanoformulations for therapy of pancreatic and liver cancers.Yolk/shell nanoparticles: classifications, synthesis, properties, and applications.Design, synthesis and applications of core-shell, hollow core, and nanorattle multifunctional nanostructures.
P2860
Q26827998-F899E16E-010C-47D1-B85B-8E8D003D4525Q26849404-BD90EBBC-F552-49F9-A260-A6BFC6D458F6Q28383168-45818E7A-FD35-4569-84C0-EE186D983592Q28487464-46FEFA20-75C7-4FC5-BAD2-7834C03CC30FQ30416999-0D5A2463-F610-49F3-A754-6A22473AA9FBQ30597217-BA5F2449-43F9-4E95-A4C2-63B9ED43D02BQ33594253-15BF5D77-60A0-4A54-81F9-EB23728B2E69Q33687218-32DF5ACF-D543-4D4D-BAC8-03E6CB4B333EQ33857638-AE82B462-BFF9-4416-A55A-4A35D9AA9A9CQ34115878-FFBAB7D3-FBD2-4FE7-A79E-19219B00A9D8Q34763969-A607D2B6-1AB1-4679-82D9-395BC017BE96Q34811465-0BD218A4-3EFA-41F3-841F-2424F83CC921Q35099618-0E58F69C-9A0A-492F-8CEC-4170B1528E16Q35602386-FB0E2708-1EFE-4EFD-AC18-E8DB81EF21EFQ35610814-AC49F9BF-99DE-4026-9D0E-E0FBB94377E5Q35624609-2D3DDAEB-A38C-41DF-A015-4D0E7E57FDF3Q35895637-FAE3A1FD-3159-4784-9E16-4EBEEF24CC2DQ35978871-B7E8B343-63E1-4FD0-98B1-DA2D51DDEA8DQ36064150-6E86D3DF-1DAE-4543-8B60-357272C717D0Q36390248-64DFC4FB-F655-4901-8519-6AC7B83FB752Q36562731-21635E59-ACF3-4E79-9446-D83A9CFBFA5DQ36872863-14E82912-29B2-42CE-8C0A-F0523D532A6DQ36971700-020113EE-5EEC-4BA1-8F34-6D8539BDABD6Q37091683-7F6E8357-3CEC-4EAB-89D7-33E06CE4DF37Q37131939-748E9769-E3D2-4869-BF49-35118F5F948BQ37202291-1770A73C-C6B1-48B6-8BF6-01524EDD70ACQ37403555-9DCB23CA-42F8-4E5F-8354-D9AC445F5181Q37624164-32E64C85-9316-4093-B6B5-3548E0CE90AFQ37687455-080A970D-16A8-4710-804C-527863C51D0BQ37932417-2E00160A-75B1-4055-9062-48A646FE294DQ38001430-09AE7970-B6D1-430E-A4B6-1E1A5256B606Q38003964-48E4FC52-5D83-46D5-B9AE-6BD5D9FD3E5CQ38014497-491C08EB-5AE3-4AB6-B04E-CBFF9231C898Q38019047-A04B220B-BDF7-4DEB-8E68-C8FC6F09D01BQ38080729-846F6FCC-D7E0-40B7-8E12-08225E68475FQ38215663-FAF1B164-E5EE-4C22-BD7B-8C19F2FC2E1EQ38225630-4705E889-06F2-412F-AEDB-41F909CE6F99Q38495105-F015DBDB-CDE6-4982-A714-02EF901A3B7DQ38633392-6AF08E32-A5F7-43BD-8D33-F2D2B23966EAQ38696415-A5FEA02D-8A4A-4D09-AE22-C933EBCD118C
P2860
In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In vivo delivery of silica nan ...... ow toxicity and high efficacy.
@en
In vivo delivery of silica nan ...... ow toxicity and high efficacy.
@nl
type
label
In vivo delivery of silica nan ...... ow toxicity and high efficacy.
@en
In vivo delivery of silica nan ...... ow toxicity and high efficacy.
@nl
prefLabel
In vivo delivery of silica nan ...... ow toxicity and high efficacy.
@en
In vivo delivery of silica nan ...... ow toxicity and high efficacy.
@nl
P2093
P356
P1433
P1476
In vivo delivery of silica nan ...... low toxicity and high efficacy
@en
P2093
Fangqiong Tang
Tianlong Liu
P304
P356
10.1021/NN100918A
P407
P50
P577
2010-10-25T00:00:00Z